← Back to headlines
NRx Pharmaceuticals (NRXP) Positioned for Growth in Depression and PTSD Treatment
NRx Pharmaceuticals, Inc. (NRXP) stock is seen as positioned for growth. This is attributed to its innovation in treatments for depression and PTSD.
15 Jul, 09:21 — 15 Jul, 09:21
Sources
Showing 1 of 1 sources
